| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $515K | -74.3% | -72.0% |
| Cost of Revenue | $1.6M | +77.2% | +49.1% |
| Gross Profit | $1.0M | -10.2% | +27.6% |
| R&D Expense | $131K | -7.7% | +47.2% |
| SG&A Expense | $1.0M | +10.6% | +56.3% |
| Operating Income | -$1.4M | -131.4% | -3.8% |
| Pre-tax Income | -$1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.5M | +4.9% | +89.5% |
| Accounts Receivable | $506K | +27.1% | +54.7% |
| Inventory | $3.3M | +15.3% | +49.5% |
| Current Assets | $9.1M | +8.0% | +52.7% |
| Total Assets | $11.7M | +18.2% | +65.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | — |
| Capital Expenditures | $16K | — | — |
| Investing Cash Flow | -$196K | — | — |
| Financing Cash Flow | $2.7M | — | — |
| Free Cash Flow | -$2.8M | — | — |
| -196.7% |
| -2.7% |
| Net Income | -$1.3M | -196.7% | -2.7% |
| EPS (Basic) | -$0.40 | -166.7% | +68.0% |
| EPS (Diluted) | -$0.40 | -166.7% | +68.0% |
| $3.3M |
| +54.2% |
| +39.7% |
| Long-term Debt | $832K | +804.3% | +370.1% |
| Total Liabilities | $4.4M | +78.0% | +69.3% |
| Stockholders' Equity | $7.3M | -1.6% | +63.7% |